TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
TECH

Bio-Techne Corp

Healthcare · Biotechnology

72.50$ +0.1% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow TECH
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
30.8% 28.8% 25.5% 26.5% 25.4% 27.8% 37.8% 29.4% 22.4% 25.8% 23.6% 24.0%
8.2% 8.6% 10.7% 10.0% 10.9% 11.2% 9.4% 9.1% 9.4% 9.6% 9.0% 8.0%
1.3% 1.9% 2.6% 4.4% 4.5% 4.4% 5.3% 3.8% 3.5% 3.3% 3.3% 3.4%
1.3% 2.9% 4.1% -3.4% 2.9% 5.9% 10.2% -4.3% -3.3%
-2.5% -3.0% -2.5% 0.3% -3.9% -0.7% 3.1% -6.3% -4.2% -0.9% 0.9% -3.4%
4.4% 3.4% 2.7% 3.3% 3.6% 7.0% 4.8% 4.1% 3.4% 5.4% 2.5% 2.4%
-94.3% -21.6% -54.3% -6.0% -47.2% 3.7% -26.2% -8.8% -23.4% -17.5% -2.9% -1.5%
10.4% 9.5% 8.4% 7.5% 6.8% 6.6% 5.3% 4.5% 4.4% 4.3% 4.1% 4.1%
2.2% 1.1% 0.9% 3.0% -2.2% -6.8% -4.6% -14.6% -1.7% -6.9% -22.6% -3.4%
15.0% 3.7% 44.8% -0.7% 23.3% -20.1% -1.7% -7.7% 8.3% -2.7% 2.2% -12.0%
6.9% -4.6% 33.6% -15.4% 18.8% -24.9% -6.7% -22.0% 2.0% -10.6% -20.8% -13.9%
-58.4% 1.9% 4.9% 4.7% -3.0% 6.2% 5.6% -2.4% 0.7% -2.5% 0.9% 8.4%
26.4% 25.4% 22.8% 23.2% 21.9% 20.8% 33.1% 25.4% 19.0% 20.4% 21.0% 21.7%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?